Puva cream therapy

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

UVA irradiation after local application of methoxsalene as photosensitizer in the form of a cream. Advantages are the lack of systemic NW in external application of Methoxsalen in contrast to peroral therapy (see also PUVA therapy, systemic).

ImplementationThis section has been translated automatically.

Apply Methoxsalen cream ( R162, R164, R163 ) to the affected areas. One hour after applying the cream, irradiation with UVA takes place. Only the affected areas are irradiated. The first dose after MPD, as a rule 0.2-0.3 J/cm2 (depending on skin type) is started. Increase of the UVA dose after 72 hours at the earliest. (delayed phototoxicity); usually by 0.2-0.3 J/cm2 after every 3rd irradiation Frequency of irradiation 3-4 times/week.

Undesirable effectsThis section has been translated automatically.

If the concentration of the methoxsalene is too high or the radiation dose is too high, there is a risk of dermatitis solaris.

PreparationsThis section has been translated automatically.

Authors

Last updated on: 29.10.2020